CompletedNCT04591678

Adults With SMA Treated With Nusinersen

Studying Autosomal dominant adult-onset proximal spinal muscular atrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ohio State University
Principal Investigator
Bakri Elsheikh, MD
Ohio State University
Intervention
nusinersen(drug)
Enrollment
15 enrolled
Eligibility
18-60 years · All sexes
Timeline
20182021

Study locations (1)

Collaborators

Biogen · Cure SMA

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04591678 on ClinicalTrials.gov

Other trials for Autosomal dominant adult-onset proximal spinal muscular atrophy

Additional recruiting or active studies for the same condition.

See all trials for Autosomal dominant adult-onset proximal spinal muscular atrophy

← Back to all trials